Lanreotide + NateglinideModerate
Somatostatin analogue that may reduce blood-glucose-lowering effect and increase susceptibility to hyperglycemia. Dose increases and increased glucose monitoring may be required.
Source: NLP:nateglinide
1 interaction on record
Somatostatin analogue that may reduce blood-glucose-lowering effect and increase susceptibility to hyperglycemia. Dose increases and increased glucose monitoring may be required.
Source: NLP:nateglinide